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Abstract Liposomes of 400 nm in diameter can cross the 100-
nm fenestrations in the endothelium of the hepatic sinusoid,
provided they contain phosphatidylserine (PS) but not phospha-
tidylglycerol (PG) [Daemen et al. (1997) Hepatology 26, 416].
We present evidence indicating that (i) the PS effect does not
involve a pharmacological action of this lipid on the size of the
fenestrations, (ii) fluid-type but not solid-type PS liposomes have
access to the hepatocytes and (iii) the lack of uptake of PG
liposomes by hepatocytes is not due to a lack of affinity of the
hepatocytes for PG surfaces. We conclude that the mechanism
responsible for the uptake of large PS-containing liposomes by
hepatocytes in vivo involves a mechanical deformation of these
liposomes during their passage across the endothelial fenestra-
tions.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
The use of particulate drug carriers such as liposomes to
optimize the payload for the cell-speci¢c delivery of drugs
o¡ers the advantage that one such carrier unit may contain
a large number of active drug molecules. This approach may
be particularly favorable for readily accessible cells such as
circulating blood cells, endothelial cells of the vascular system
or tissue macrophages such as Kup¡er cells in the liver. It
may, however, present a serious problem for target cells out-
side the circulation because of anatomical constraints. In this
respect, the liver is an exceptional organ because of the nu-
merous open fenestrations in the endothelial lining of the
sinusoid. This condition provides an almost unrestricted ac-
cessibility of trans-endothelially located cell populations such
as the hepatocytes and the stellate cells for particles with sizes
well below the diameter of the fenestrations, i.e. approxi-
mately 100 nm [1,2]. In the past, the usefulness of liposomes
for the delivery of large quantities of drugs to Kup¡er cells
has been demonstrated extensively by us [3] as well as by
several others [4,5]. Recently, we showed that liposomes can
also be delivered e¡ectively to the sinusoidal endothelial cells,
when targeted with a proper ligand for the scavenger receptor
on these cells [6,7] but also that liposomes with diameters of
up to 400 nm may gain access to the hepatocytes, provided
they have the proper lipid composition, i.e. they should con-
tain the negatively charged component phosphatidylserine [8].
We tentatively explained this observation by assuming that
either the phosphatidylserine was acting as a pharmacologi-
cally active agent causing an increase in the average diameter
of the fenestrations or the liposomes were forcefully squeezed
or ‘extruded’ through the fenestrations, possibly mediated by
a process of forced sieving involving blood cells, as proposed
earlier by Wisse et al. [9]. We now present evidence arguing
against the pharmacological option and in favor of the extru-
sion concept.
2. Materials and methods
2.1. Animals
Pathogen-free male Wag/Rij rats (Harlan CPB, Zeist, The Nether-
lands), weighing 200^250 g, were used throughout the experiments.
The animals received care in accordance with the institution’s guide-
lines.
2.2. Materials
All phospholipids were purchased from Avanti Polar Lipids
(Alabaster, AL, USA). Cholesterol was obtained from Sigma Co.
[3H]Cholesteryl-oleylether (speci¢c activity 1.7 MBq/mmol) was a
product of Amersham (Buckinghamshire, UK). Collagenase A was
obtained from Boehringer Mannheim (Almere, The Netherlands).
All other chemicals were obtained from Merck or Sigma and of the
highest purity available.
2.3. Preparation of liposomes
Liposomes were prepared from phosphatidylcholine (PC), choles-
terol (CHOL) and either phosphatidylserine (PS) or phosphatidylgly-
cerol (PG) in a 5:4:1 molar ratio. PC was either from egg yolk or
synthetic distearoyl-PC and PS was either from bovine brain or syn-
thetic distearoyl-PS. PG was in all cases PG derivatized from egg-PC.
The lipid mixture, labeled, when required, with [3H]cholesteryl-oleyl-
ether (3.6 kBq/Wmol total lipid), was dried down from chloroform/
methanol 9:1 stock solutions under reduced nitrogen pressure. The
dried lipids were then hydrated with bu¡er (135 mM NaCl/10 mM
HEPES (4-[2-hydroxyethyl]-L-piperazine ethanesulfonic acid), pH 7.4)
and shaken for 10 min either at room temperature, or, for the dis-
tearoyl lipid mixture, at 60‡C. The liposomes thus obtained were ex-
truded repeatedly either through two polycarbonate membranes (Co-
star, Nuclepore, Cambridge, MA, USA) of 400 nm pore diameter
alone, in order to obtain the larger size liposomes, or three times
through membranes of 400 and 200 nm pore size consecutively and
10 times through 50 nm pore size to obtain the small-size liposomes.
Extrusion was carried out at room temperature except for the solid-
type liposomes which were extruded at 60‡C. The average size and
size distribution of the two types of liposomes thus obtained was
determined by dynamic light scattering employing a Nicomp particle
analyzer, model 370 (Nicomp Particle sizing systems, Santa Barbara,
CA, USA). The average size of the large £uid liposomes was 336.6 nm
with a mean S.D. of 134.8 (n = 5), and of the large solid liposomes
297.7 þ 114.1 nm (n = 3), both measured in the solid particle mode.
Average size of the small £uid liposomes was 77.9 nm with a mean
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S.D. of 25.3 (n = 3) and of the small solid liposomes 157.1 þ 57.2 nm
(n = 3), both measured in the vesicle mode. The lipid content of ¢nal
preparations was determined by lipid phosphorus assay [10], which
also served to calculate the speci¢c radioactivity of the preparations
(Bq/Wmol of lipid). Liposome preparations were stored under nitrogen
at 4‡C and used within 2 weeks of preparation.
2.4. Intrahepatic distribution
Rats were injected intravenously via the vena penis with 5 or
10 Wmol liposomal lipid. Two or 24 h after injection, hepatocytes
and hepatic non-parenchymal cells were isolated as described before
[8,11]. Brie£y, livers were pre-perfused for 5 min with perfusion bu¡er
containing EGTA to remove blood. After another brief perfusion with
Ca2-containing perfusion medium, the liver was connected to a re-
circulating perfusion system and perfusion was continued for another
10 min with perfusion medium containing collagenase and Ca2.
From the liver cell suspension thus obtained parenchymal cells were
isolated by low-speed sedimentation; non-parenchymal cells were iso-
lated from the supernatant by means of centrifugation for 15 min at
1500Ug on a Nycodenz concentration gradient (Nycomed, Oslo, Nor-
way). Cells were counted and aliquots were taken for radioactivity
measurements.
It should be appreciated that cholesteryl-oleyl-ether (CE) is widely
acknowledged as a metabolically inert compound that remains ¢rmly
associated with cells after internalization [12]. In accordance, we dem-
onstrated earlier that liposomal [3H]CE is released from Kup¡er cells
in vitro at a rate of less than 0.5% h31 [13]. We also observed recently
that the encapsulated liposomal markers [14C]sucrose and colloidal
gold produce essentially the same intrahepatic distribution patterns
as the lipid bilayer label [3H]CE [8]. It is therefore justi¢ed to exclude
any involvement of a selective [3H]CE label transfer from Kup¡er
cells to hepatocytes in the delivery of liposomal [3H]CE to the latter
cell type. Furthermore, label transfer from endothelial cells can be
discarded because these cells in vivo do not engage in the uptake of
non-targeted liposomes [7,14].
3. Results
In our previous paper [8] we suggested as one of the possi-
ble explanations for the drastically di¡erent intrahepatic dis-
tribution of PS and PG liposomes, that the PS might have a
pharmacological e¡ect on the fenestrations, causing an in-
crease of their size. The results presented in Fig. 1 demon-
strate, however, that the simultaneous presence of large unla-
beled PS-containing liposomes has no e¡ect on the
intrahepatic distribution of large (350 nm) PG-containing lip-
osomes. Both with PG liposomes alone and with PG lipo-
somes combined with PS liposomes not more than 3% of
the total liver-associated PG liposomes distribute to the hep-
atocytes. For comparison we included an experiment with
labeled PS liposomes. The result con¢rmed our previous ob-
servation, i.e. these liposomes distribute approximately
equally between parenchymal and non-parenchymal cells, in-
dicating as observed before, that the PS liposomes e⁄ciently
reach the hepatocytes. From these results we conclude that the
di¡erence in hepatic distribution between PS and PG lipo-
somes is unlikely to be due to a pharmacological e¡ect of
the PS on the size of the fenestrations.
It might be argued that the lack of uptake of PG liposomes
by hepatocytes, as presented in Fig. 1 is due an intrinsic lack
of a⁄nity of the hepatocyte for the PG. Therefore, we carried
out an experiment with PG liposomes of su⁄ciently small size
(approximately 80 nm) to allow easy passage through the 100-
nm fenestrations. Fig. 2 shows the result. As much as two
thirds of the total liver-associated amount of small PG lip-
osomes were taken up by the hepatocytes. For comparison we
again included the intrahepatic distribution of the large PG
liposomes, with only 2^3% in the hepatocytes, and of the large
PS liposomes with a ¢fty/¢fty distribution. Clearly, the hep-
atocytes are able to recognize, bind and internalize PG-con-
taining liposomes once they have gained access to these cells
by virtue of their small size.
If it is not a PS-induced widening of the diameter of the
fenestrations that is responsible for the trans-endothelial pas-
sage of the large PS liposomes, the alternative explanation we
o¡ered in our previous paper should be considered, i.e. a
mechanical e¡ect by which the liposomes are forced across
the fenestrae, conceivably mediated by mechanical action of
white blood cells being squeezed along the narrow sinusoid.
This option was taken from an idea proposed earlier by
Wisse, who introduced the concept of forced sieving and en-
dothelial massage in order to explain the movement of £uid
into and out of the space of Disse [9]. If such a forced ex-
trusion of liposomes were to take place, one would have to
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Fig. 1. The presence of PS liposomes does not in£uence the intrahe-
patic distribution of PG liposomes. Large radiolabeled PG lipo-
somes were injected either as such or mixed with an equal amount
of unlabeled PS liposomes. For comparison, radiolabeled PS lipo-
somes were injected. Intrahepatic distribution after 4 h is given as
percent of total liver-associated radioactivity þ S.D. Filled bars,
hepatocytes; open bars, non-parenchymal cells. * indicates the lipo-
some type that was labeled.
Fig. 2. Hepatocytes are able to take up small PG liposomes. Small
radiolabeled PG liposomes were injected and after 24 h the distribu-
tion of radioactivity between parenchymal and non-parenchymal
cells of the liver was determined. For comparison, intrahepatic dis-
tribution of large PG liposomes as well as of large PS liposomes is
included. Filled bars, hepatocytes; open bars, non-parenchymal
cells ; error bar, S.D.
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assume that these liposomes have to be deformable. For a
liposome to be deformable its bilayers should be in a relatively
£uid (liquid-crystalline) state [15], as is likely to be the case for
egg PC/brain PS/CHOL liposomes with a high content of
(poly)unsaturated hydrocarbon chains. The bilayers of
DSPC/DSPS/CHOL liposomes, on the other hand, with
only saturated long chain hydrocarbon moieties, are much
more rigid and thus less £exible. Therefore, we repeated our
previous experiment on PS liposomes, but now composed of
the rigid mixture DSPC/DSPS/CHOL and both small and
large in size. Fig. 3 demonstrates that in contrast to our ¢nd-
ings on large 350-nm egg PC/PS/CHOL liposomes in Figs. 1
and 2, the large DSPC/DSPS/CHOL liposomes almost only
associate with the non-parenchymal cells. The hepatocytes
take up negligible quantities of these liposomes. This lack of
uptake of rigid PS liposomes by hepatocytes is not due to an
intrinsic lack of a⁄nity of these cells for rigid PS surfaces.
This is demonstrated by the right panel of Fig. 3, which shows
that a substantial proportion of small liposomes of this rigid
composition associates with hepatocytes and therefore does
gain access to these cells.
4. Discussion
Widely varying compounds like ethanol and serotonin have
been shown to a¡ect the diameter of endothelial fenestrae
[16,17]. Furthermore, PS and/or its metabolites have been
reported to possess a variety of pharmacological activities
[18,19]. PS was also shown to stimulate phosphorylation of
actin by protein kinase C in a strongly concentration-depend-
ent way [20], while cytoskeletal elements have been reported
to be closely associated with the fenestrae [21]. Thus, we con-
sidered it conceivable that PS-containing liposomes might ex-
ert a dilating e¡ect on the fenestrae. However, the lack of
e¡ect of PS liposomes on the intrahepatic distribution of
PG liposomes, as presented in Fig. 1, strongly argues against
a speci¢c pharmacological e¡ect of the PS causing a dilation
of the fenestrations. Nor can an intrinsic lack of a⁄nity of the
hepatocyte for PG-containing liposomes account for the dif-
ference between the two liposome types, as was clearly shown
by the results presented in Fig. 2. If there is no increase in the
size of the fenestrations and if the PS liposomes do not lose
signi¢cant amounts of an encapsulated marker during their
passage across the endothelium, as we demonstrated in our
previous paper [8], the large PS liposomes must pass through
the fenestrations intact. The results presented in Fig. 3 suggest
that such passage involves the deformation of the liposomal
bilayer so as to adjust the shape of the liposome to the much
smaller size of the fenestrae, because the non-£exible rigid-
bilayer liposomes containing PS apparently do not have access
to the hepatocytes.
An important question that remains to be answered is why
£uid-type PS liposomes apparently do and £uid-type PG lip-
osomes do not reach the hepatocytes. At present we can only
address this question in a speculative way. For a PS liposome
to be squeezed into and through a fenestra it probably has to
experience in the vascular compartment some degree of retar-
dation in the vicinity of the fenestra, conceivably achieved by
a reversible interaction between the liposome and the endo-
thelium. Such an interaction might be mediated by scavenger
receptors which we showed to be present on these cells and
which we hold responsible for the massive in vivo uptake of
liposomes carrying covalently coupled poly-aconitylated (and
thus strongly anionic) albumins on their surface [6,7]. Despite
their multiple negative charges, liposomes containing up to
100% of PS do not irreversibly interact with these receptors
in vivo, as revealed by their complete lack of association with
endothelial cells isolated following intravenous injection of
such liposomes, but these liposomes do interact strongly
with these cells in vitro, provided no serum is present (Kamps
et al., unpublished observations). In addition, we observed
that PS-containing liposomes, during the ¢rst 5 min following
their intravenous administration, transiently accumulate in the
liver (Kamps et al., unpublished observations). On the basis of
these observations we speculate that the negative charges of
bilayer-associated PS are able to transiently associate with the
endothelial cells, while PG liposomes with their more con-
cealed negative charges do not or do so to a lesser extent.
In conclusion, the experiments described in this paper give
reason to believe that the speci¢c ability of large PS-contain-
ing liposomes to penetrate the hepatic sinusoidal endothelium
so as to gain access to the liver parenchymal cells lying across
the endothelial lining involves a possibly blood cell-mediated
[9], forced extrusion of the liposomes through the endothelial
fenestrae, by virtue of a weak and transient interaction with
sites on the endothelium conceivably represented by scavenger
receptors. The notion that even relatively large liposomes may
thus reach trans-endothelial areas in the liver opens up possi-
bilities of using large liposomes to e⁄ciently deliver even large
molecules such as proteins and DNA, which are di⁄cult to
encapsulate in small vesicles, to cells located there, such as
hepatocytes and stellate cells.
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Fig. 3. Large rigid-bilayer PS liposomes do not have access to hepa-
tocytes. Small and large radiolabeled liposomes consisting of DSPC,
DSPS and CHOL (5:1:4) were injected and intrahepatic distribution
was determined. Filled bars, hepatocytes; open bars, non-parenchy-
mal cells; error bar, S.D.
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